Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Cancer
    September 2025
  1. NIERENGARTEN MB
    Neoadjuvant immunochemotherapy for nonsurgical HPV-negative head and neck cancer.
    Cancer. 2025;131:e70036.
    >> Share

    August 2025
  2. BAI M, Lu Y, Shen L, Yin X, et al
    Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial.
    Cancer. 2025;131:e70046.
    >> Share

    July 2025
  3. NIERENGARTEN MB
    Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer.
    Cancer. 2025;131:e35924.
    >> Share

  4. HAUGEN CANGE H, Hogmo A, Sandstrom K, Wennerberg J, et al
    Radiotherapy or surgical treatment of early glottic carcinoma: A population-based study from the Swedish Head and Neck Cancer Register evaluating primary treatment outcomes for patients with T1a/T1b tumors.
    Cancer. 2025;131:e35955.
    >> Share

    April 2025
  5. SAHIN O, Kamel S, Wahid KA, Dede C, et al
    International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Prospective blinded human inter-observer performance evaluation.
    Cancer. 2025;131:e35815.
    >> Share

    January 2025
  6. KHANNA D, Mishra A, Birur P, Shruti T, et al
    A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India.
    Cancer. 2025;131:e35702.
    >> Share

    December 2024
  7. NGUYEN T, Koric A, Chang CE, Barul C, et al
    Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
    Cancer. 2024 Dec 23. doi: 10.1002/cncr.35620.
    >> Share

  8. NIERENGARTEN MB
    First person profile: Quynh-Thu Le, MD: Dr Le confronts the difficult challenges of improving the efficacy and safety of radiation therapy in the treatment of head and neck cancers.
    Cancer. 2024;130:4164.
    >> Share

  9. ABYANEH R, Ghalehtaki R, Sanford NN
    Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review.
    Cancer. 2024;130:4040-4051.
    >> Share

  10. NIERENGARTEN MB
    Promising long-term disease control and survival with pembrolizumab and cabozantinib for head and neck cancer.
    Cancer. 2024;130:3947.
    >> Share

  11. NIERENGARTEN MB
    Increased head and neck cancer linked to cannabis use.
    Cancer. 2024;130:3946.
    >> Share

    November 2024
  12. DAY AT, Mitchell DN, Eary RL, Jones E, et al
    Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors.
    Cancer. 2024 Nov 26. doi: 10.1002/cncr.35639.
    >> Share

  13. BERZENJI D, Oude Booijink ORG, Gahrmann R, Mast H, et al
    A comprehensive approach to defining the cutoff value of oligometastasis in head and neck squamous cell carcinoma.
    Cancer. 2024 Nov 5. doi: 10.1002/cncr.35632.
    >> Share

    August 2024
  14. WU Q, Hu C, Feng L, Yang X, et al
    Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.
    Cancer. 2024 Aug 14. doi: 10.1002/cncr.35517.
    >> Share

    July 2024
  15. SALZ T, Meza AM, Bradshaw PT, Jinna S, et al
    Role of primary care in opioid prescribing for older head and neck cancer survivors.
    Cancer. 2024 Jul 27. doi: 10.1002/cncr.35478.
    >> Share

  16. GOODMAN KA, Hotca A, Liu M, Strong VE, et al
    Top advances of the year: Gastroesophageal cancer.
    Cancer. 2024;130:2253-2256.
    >> Share

    June 2024
  17. NIERENGARTEN MB
    First person profile: Everett Vokes, MD: Pioneer of the combination of radiation and chemotherapy as the first line of treatment for head and neck cancer.
    Cancer. 2024;130:2082-2083.
    >> Share

  18. NIERENGARTEN MB
    FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Cancer. 2024;130:1903.
    >> Share

    May 2024
  19. NING T, Li D, Deng T, Bai Y, et al
    Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
    Cancer. 2024 May 23. doi: 10.1002/cncr.35377.
    >> Share

  20. NIERENGARTEN MB
    First person profile: Barbara Burtness, MD: For more than 20 years, she has applied advances in molecular biology to better treat patients with head and neck cancers.
    Cancer. 2024;130:1724.
    >> Share

    March 2024
  21. CONTRERA KJ, Patel MR, Burtness B, Mehra R, et al
    The role of surgery and deescalation for HPV-related oropharyngeal cancer.
    Cancer. 2024 Mar 18. doi: 10.1002/cncr.35287.
    >> Share

  22. HO AL, Foster NR, Deraje Vasudeva S, Katabi N, et al
    A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
    Cancer. 2024;130:702-712.
    >> Share

    February 2024
  23. CHOI H, Cho SW, Kim HH, Yi KH, et al
    Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma.
    Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
    >> Share

  24. DE ALMEIDA JR, Su JS, Kolarski MM, Truong T, et al
    Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma.
    Cancer. 2024;130:410-420.
    >> Share

    January 2024
  25. GROSS ND, Seiwert TY
    Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
    Cancer. 2024 Jan 18. doi: 10.1002/cncr.35198.
    >> Share

  26. NIERENGARTEN MB
    Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
    Cancer. 2024;130:172.
    >> Share

  27. NIERENGARTEN MB
    Oral health linked to survival in head and neck cancer.
    Cancer. 2024;130:171.
    >> Share

    December 2023

  28. Researchers identify two new subtypes of HPV-associated head and neck cancers.
    Cancer. 2023;129:3842.
    >> Share

    October 2023
  29. CARPENTER DJ, Patel P, Niedzwiecki D, Dillon M, et al
    Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancer.
    Cancer. 2023 Oct 28. doi: 10.1002/cncr.35089.
    >> Share

  30. MORAND GB, Eskander A, Fu R, de Almeida J, et al
    The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative.
    Cancer. 2023;129:3263-3274.
    >> Share

  31. PHILIPS R, Alnemri A, Amin D, Patel J, et al
    Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
    Cancer. 2023 Oct 3. doi: 10.1002/cncr.35045.
    >> Share

    September 2023
  32. ZHANG L, San Valentin EMD, John TM, Jenq RR, et al
    Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2023 Sep 8. doi: 10.1002/cncr.35001.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016